Deveron - President and CEO, David MacMillan.
President and CEO, David MacMillan.
Source: Deveron.
  • Deveron (FARM) has announced a non-brokered private placement financing of C$3.5 million
  • The company will issue 5,384,615 units priced at $0.65 per unit
  • Proceeds will go toward working capital and general corporate purposes
  • Deveron uses agricultural technology to help farmers increase yields, reduce costs and improve outcomes
  • Deveron (FARM) is down by 1.56 per cent and is currently trading at $0.63 per share

Deveron (FARM) has announced a non-brokered private placement financing of C$3.5 million.

The company will issue 5,384,615 units priced at $0.65 per unit.

Each unit is comprised of one Deveron common share and one-half of one common share purchase warrant.

Each warrant entitles the holder to acquire one common share for $0.85 for two years from the date of issuance.

The company will use the proceeds for working capital and general corporate purposes.

Deveron uses agricultural technology to help farmers increase yields, reduce costs and improve outcomes.

Deveron (FARM) is down by 1.56 per cent and is currently trading at $0.63 per share as of 10:56 am ET.

More From The Market Online

Med-X, Inc.: Investing in the future of natural pest control

Med-X, Inc. prepares for a NASDAQ listing, investors can evaluate a company in the world’s most essential industries: pest control.

The 5-Minute Investor Podcast, Ep. 82: Canadian stocks with European potential

Have a listen to episode 82 of The 5-Minute Investor Podcast, featuring analysis on Canadian stocks Nutrien and Mont Royal Resources.

Which potash stock could benefit from the Canada / US trade war?

Canada could face challenges if the U.S. reduces its reliance on Canadian potash, but stronger E.U. trade ties could help expand Euro sales.
The Market Online Video

Med-X targets global pest control market with Nature-Cide

Med-X CEO Matthew Mills discusses Nature-Cide, professional pest control partnerships, global expansion and the company’s planned Nasdaq listing.